(Q37768443)

22 August 2017

1 reference

title

What is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression? (English)

1 reference

22 August 2017

0 references

Daniele Marano Rocha Araujo

series ordinal

1

1 reference

22 August 2017

Marina Machado Vilarim

series ordinal

2

1 reference

22 August 2017

Antonio E Nardi

series ordinal

3

1 reference

22 August 2017

publication date

1 July 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

1117-1129

1 reference

Foods with a high fat quality are essential for healthy diets

22 August 2017

cites work

1 reference

Omega-3 fatty acids and bipolar disorder: a review

21 January 2018

1 reference

No clear evidence of an association between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a non-clinical population

21 January 2018

1 reference

A concordance correlation coefficient to evaluate reproducibility

21 January 2018

1 reference

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

21 January 2018

1 reference

High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism

21 January 2018

1 reference

Depressive symptoms during pregnancy in relation to fish consumption and intake of n-3 polyunsaturated fatty acids

21 January 2018

1 reference

Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers.

21 January 2018

1 reference

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

21 January 2018

1 reference

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

Depression and adipose polyunsaturated fatty acids in the survivors of the Seven Countries Study population of Crete

21 January 2018

1 reference

A rating scale for depression

21 January 2018

1 reference

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.

21 January 2018

1 reference

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.

21 January 2018

1 reference

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

21 January 2018

1 reference

Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study.

21 January 2018

1 reference

Adipose DHA inversely associated with depression as measured by the Beck Depression Inventory.

21 January 2018

1 reference

Health benefits of docosahexaenoic acid (DHA)

21 January 2018

1 reference

Fish consumption and major depression

21 January 2018

1 reference

Lipid mediators in inflammatory disorders

21 January 2018

1 reference

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

21 January 2018

1 reference

Dietary Omega-3 Fatty Acids and Depression in a Community Sample

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.10.77

1 reference

22 August 2017

1 reference